VivoSim Labs, Inc. (VIVS) Financials
VIVS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 3.8 million | 6.2 million |
| March 31, 2026 | 7.4 million | 8.5 million |
| Dec. 31, 2025 | 7.0 million | 2.5 million |
| Sept. 30, 2025 | 9.7 million | 2.6 million |
VIVS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -3.2 million | 91000 |
| March 31, 2026 | -2.2 million | 86000 |
| Dec. 31, 2025 | -2.3 million | 67000 |
| Sept. 30, 2025 | -2.4 million | 72000 |
VIVS Net Income
No data available :(
VIVS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.7 million | - | 316000 |
| March 31, 2026 | 5.0 million | - | 447000 |
| Dec. 31, 2025 | 4.3 million | - | 577000 |
| Sept. 30, 2025 | 6.7 million | - | 700000 |
VIVS Shares Outstanding
VIVS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 23000 | 1.1 million | 1.6 million | - |
| March 31, 2026 | - | 1.1 million | 1.9 million | - |
| Dec. 31, 2025 | - | 1.1 million | 1.6 million | - |
| Sept. 30, 2025 | - | 923000 | 1.7 million | - |
VIVS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 18000 | 263000 |
| March 31, 2026 | 40000 | 263000 |
| Dec. 31, 2025 | 26000 | - |
| Sept. 30, 2025 | 28000 | - |
VIVS
Price: $0.29
52 week price:
Earnings Per Share: -5.35 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.1 million